Lambrecht G, Feifel R, Wagner-Röder M, Strohmann C, Zilch H, Tacke R, Waelbroeck M, Christophe J, Boddeke H, Mutschler E
Department of Pharmacology, University of Frankfurt, F.R.G.
Eur J Pharmacol. 1989 Sep 1;168(1):71-80. doi: 10.1016/0014-2999(89)90634-1.
In an attempt to assess the structural requirements of hexahydro-sila-difenidol for potency and selectivity, a series of analogues modified in the amino group and the phenyl ring were investigated for their affinity to muscarinic M1-(rabbit vas deferens), M2- (guinea-pig atria) and M3- (guinea-pig ileum) receptors. All compounds were competitive antagonists in the three tissues. Their affinities to the three muscarinic receptor subtypes differed by more than two orders of magnitude and the observed receptor selectivities were not associated with high affinity. The pyrrolidino and hexamethyleneimino analogues, compounds substituted in the phenyl ring with a methoxy group or a chlorine atom as well as p-fluoro-hexahydro-difenidol displayed the same affinity profile as the parent compound, hexahydro-sila-difenidol: M1 approximately M3 greater than M2. A different selectivity pattern was observed for p-fluoro-hexahydro-sila-difenidol: M3 greater than M1 greater than M2. This compound exhibited its highest affinity for M3-receptors in guinea-pig ileum (pA2 = 7.84), intermediate affinity for M1-receptors in rabbit vas deferens (pA2 = 6.68) and lowest affinity for the M2-receptors in guinea-pig atria (pA2 = 6.01). This receptor selectivity profile of p-fluoro-hexahydro-sila-difenidol was confirmed in ganglia (M1), atria (M2) and ileum (M3) of the rat. Furthermore, dose ratios obtained with either pirenzepine (M1) or hexahydrosila-difenidol (M2 and M3) and the p-fluoro analogue used in combination suggested that the antagonism was additive, implying mutual competition with a single population of muscarinic receptor subtypes. These results indicate that p-fluoro-hexahydro-sila-difenidol represents a valuable tool for characterization of muscarinic receptor subtypes.
为了评估六氢硅二苯乙醇胺的效力和选择性的结构要求,研究了一系列在氨基和苯环上进行修饰的类似物对毒蕈碱M1(兔输精管)、M2(豚鼠心房)和M3(豚鼠回肠)受体的亲和力。所有化合物在这三种组织中均为竞争性拮抗剂。它们对三种毒蕈碱受体亚型的亲和力相差两个以上数量级,且观察到的受体选择性与高亲和力无关。吡咯烷基和六亚甲基亚氨基类似物、在苯环上被甲氧基或氯原子取代的化合物以及对氟六氢二苯乙醇胺显示出与母体化合物六氢硅二苯乙醇胺相同的亲和力谱:M1约等于M3大于M2。对氟六氢硅二苯乙醇胺观察到不同的选择性模式:M3大于M1大于M2。该化合物在豚鼠回肠中对M3受体表现出最高亲和力(pA2 = 7.84),在兔输精管中对M1受体表现出中等亲和力(pA2 = 6.68),在豚鼠心房中对M2受体表现出最低亲和力(pA2 = 6.01)。对氟六氢硅二苯乙醇胺的这种受体选择性谱在大鼠的神经节(M1)、心房(M2)和回肠(M3)中得到证实。此外,用哌仑西平(M1)或六氢硅二苯乙醇胺(M2和M3)与对氟类似物联合使用获得的剂量比表明拮抗作用是相加的,这意味着它们与单一群体的毒蕈碱受体亚型相互竞争。这些结果表明,对氟六氢硅二苯乙醇胺是表征毒蕈碱受体亚型的一种有价值的工具。